NovaBridge Biosciences NBP
NASDAQ NBP
$1.34 -0.02 (-1.83%)
At close: Oct 1, 2026 · 4:00 PM EDT

NovaBridge Biosciences (NBP) Equity Income (2023 - 2024)

Updated

NovaBridge Biosciences (NBP) recorded Equity Income of -$1.04 million in FY2024, compared with -$11.4 million in FY2023.

Analysis

NovaBridge Biosciences (NBP) Equity Income (2023 - 2024) Analysis & Trends

Starting with FY2020, NovaBridge Biosciences' Equity Income history includes 5 years.

  • The FY2024 figure is the highest annual Equity Income in data going back to FY2020.
  • Per Business Quant data, NBP's Equity Income was -$11.4 million in FY2023, -$64.71 million in FY2022, -$57.73 million in FY2021 and -$16.64 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -10.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 NovaBridge Biosciences 150.88 Mn 150.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -1.04 Mn
Dec 31, 2023 -764,000.00
Sep 30, 2023 -2.45 Mn
Jun 30, 2023 -1.99 Mn
API Access

NovaBridge Biosciences Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=NBP&period=max&api_key=YOUR_API_KEY